Choriocarcinoma clinical trials at UCSF
3 in progress, 2 open to eligible people
Choriocarcinoma is a type of cancer that starts in cells that would normally develop into the placenta. UCSF is exploring the effects of chemotherapy and radiation on brain tumors in young people. UCSF is also researching active surveillance as a method to watch germ cell tumors.
New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
open to eligible people ages 3-29
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other…
San Francisco, California and other locations
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
open to all eligible people
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it …
Oakland, California and other locations
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Sorry, in progress, not accepting new patients
This randomized phase III trial studies how well standard-dose combination chemotherapy works compared to high-dose combination chemotherapy and stem cell transplant in treating patients with germ cell tumors that have returned after a period of…
San Francisco, California and other locations
Our lead scientists for Choriocarcinoma research studies include Jennifer G. Michlitsch Alyssa T. Reddy Arun A. Rangaswami.
Last updated: